Correspondence 0001140361-26-024928 from Opus Genetics, Inc. (IRD)
Opus Genetics, Inc.
Date: June 11, 2026 · CIK: 0001228627 · Accession: 0001140361-26-024928
AI Filing Summary & Sentiment
File numbers found in text: 333-296551
Letter
Re:
June 11, 2026
Via EDGAR
U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720
Attention:
Tyler Howes
Opus Genetics, Inc.
Registration Statement on Form S-3 File No. 333-296551
Acceleration Request Requested Date: June 15, 2026 Requested Time: 4:00 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Opus Genetics, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on June 15, 2026, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
Please contact Nick DeAngelis of Sidley Austin LLP at (214) 969-3563 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
Very truly yours,
/s/ Dr. George Magrath
Show Raw Text
CORRESP 1 filename1.htm June 11, 2026 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Tyler Howes Re: Opus Genetics, Inc. Registration Statement on Form S-3 File No. 333-296551 Acceleration Request Requested Date: June 15, 2026 Requested Time: 4:00 P.M., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Opus Genetics, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on June 15, 2026, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Please contact Nick DeAngelis of Sidley Austin LLP at (214) 969-3563 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement. Very truly yours, /s/ Dr. George Magrath Dr. George Magrath Chief Executive Officer Opus Genetics, Inc. cc: Robert Gagnon, Opus Genetics, Inc. Asher Rubin, Sidley Austin LLP Istvan A. Hajdu, Sidley Austin LLP Nick DeAngelis , Sidley Austin LLP